ID: 127826803 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr13:102068211-102068761 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (101415860..101416410) | | |
ID: 127826802 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr13:102067660-102068210 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (101415309..101415859) | | |
ID: 127826801 | NANOG hESC enhancer GRCh37_chr13:101986545-101987100 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (101334194..101334749) | | |
ID: 127826800 | H3K4me1 hESC enhancer GRCh37_chr13:101717647-101718147 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (101065295..101065795) | | |
ID: 127826799 | H3K4me1 hESC enhancer GRCh37_chr13:101717146-101717646 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (101064794..101065294) | | |
ID: 127826798 | H3K27ac hESC enhancer GRCh37_chr13:101698875-101699376 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (101046523..101047024) | | |
ID: 126861832 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr13:102102071-102103270 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (101449720..101450919) | | |
ID: 126861831 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr13:101909917-101911116 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (101257566..101258765) | | |
ID: 126088081 | BRD4-independent group 4 enhancer GRCh37_chr13:101701141-101702340 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (101048789..101049988) | | |
ID: 124903202 | uncharacterized LOC124903202 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (101062712..101067688) | | |
ID: 121468006 | Sharpr-MPRA regulatory region 15039 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (101424458..101424752) | | |
ID: 100885778 | NALCN antisense RNA 1 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (100708325..101059286) | | |
ID: 259232 | sodium leak channel, non-selective [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (101053776..101417179, complement) | CLIFAHDD, CanIon, IHPRF, IHPRF1, INNFD, VGCNL1, bA430M15.1 | 611549 |